These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 19037879)

  • 1. Role of pravastatin in pulmonary hypertension in chronic obstructive pulmonary disease.
    Corte TJ; Wort SJ
    Clin Sci (Lond); 2009 Mar; 116(6):493-5. PubMed ID: 19037879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of pravastatin on functional capacity in patients with chronic obstructive pulmonary disease and pulmonary hypertension.
    Lee TM; Chen CC; Shen HN; Chang NC
    Clin Sci (Lond); 2009 Mar; 116(6):497-505. PubMed ID: 18831711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of C-reactive protein and interleukin-6 as predictors of outcomes in patients with chronic obstructive pulmonary disease receiving pravastatin.
    Lee TM; Lin MS; Chang NC
    Am J Cardiol; 2008 Feb; 101(4):530-5. PubMed ID: 18312772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pulmonary hypertension in COPD: a review and consideration of the role of arterial vasodilators.
    Burger CD
    COPD; 2009 Apr; 6(2):137-44. PubMed ID: 19378227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statin therapy is associated with decreased pulmonary vascular pressures in severe COPD.
    Reed RM; Iacono A; DeFilippis A; Jones S; Eberlein M; Lechtzin N; Girgis RE
    COPD; 2011 Apr; 8(2):96-102. PubMed ID: 21495837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pulmonary hypertension in chronic obstructive pulmonary disease and interstitial lung diseases.
    Weitzenblum E; Chaouat A; Canuet M; Kessler R
    Semin Respir Crit Care Med; 2009 Aug; 30(4):458-70. PubMed ID: 19634085
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pulmonary hypertension and chronic obstructive pulmonary disease: a case for treatment.
    Higenbottam T
    Proc Am Thorac Soc; 2005; 2(1):12-9. PubMed ID: 16113463
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The COPD pipeline VI.
    Gross NJ
    COPD; 2010 Oct; 7(5):383-5. PubMed ID: 20854054
    [No Abstract]   [Full Text] [Related]  

  • 9. Possible role of statins in COPD-related pulmonary hypertension.
    Young RP; Hopkins RJ
    Chest; 2010 May; 137(5):1250-1; author reply 1251. PubMed ID: 20442132
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pulmonary hypertension in COPD and interstitial lung diseases].
    Markart P; Ghofrani HA; Grimminger F; Günther A
    Dtsch Med Wochenschr; 2009 Aug; 134 Suppl 5():S164-6. PubMed ID: 19718606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Statins in COPD--theoretical reflections].
    Hannink JD; Heijdra YF
    Ned Tijdschr Geneeskd; 2010; 154():A2196. PubMed ID: 20977805
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [One-year controlled therapy with doxazosin in patients with pulmonary hypertension due to chronic obstructive pulmonary disease].
    Ludwik B; Lewczuk J; Piszko P; Nowak M; Wrabec K
    Pol Merkur Lekarski; 2006 May; 20(119):527-30. PubMed ID: 16875154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Update on pulmonary hypertension in chronic obstructive pulmonary disease].
    Onen ZP; Karabıyıkoğlu G
    Tuberk Toraks; 2010; 58(2):202-12. PubMed ID: 20865576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The overlap syndrome: obstructive sleep apnea and chronic obstructive pulmonary disease].
    Shteinberg M; Weiler-Ravel D; Adir Y
    Harefuah; 2009 May; 148(5):333-6, 348. PubMed ID: 19630366
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cor pulmonale.
    Weitzenblum E; Chaouat A
    Chron Respir Dis; 2009; 6(3):177-85. PubMed ID: 19643833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological actions of statins: potential utility in COPD.
    Young RP; Hopkins R; Eaton TE
    Eur Respir Rev; 2009 Dec; 18(114):222-32. PubMed ID: 20956147
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sildenafil therapy in secondary pulmonary hypertension: Is there benefit in prolonged use?
    Chapman TH; Wilde M; Sheth A; Madden BP
    Vascul Pharmacol; 2009; 51(2-3):90-5. PubMed ID: 19386283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [COPD and pulmonary hypertension].
    Barbero MA
    Arch Bronconeumol; 2009; 45 Suppl 4():24-30. PubMed ID: 20116746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Causes of death and prediction of mortality in COPD].
    Solanes Garcia I; Casan Clarà P
    Arch Bronconeumol; 2010 Jul; 46(7):343-6. PubMed ID: 20471740
    [No Abstract]   [Full Text] [Related]  

  • 20. Malnutrition in chronic obstructive pulmonary disease.
    Schwartz DB
    Respir Care Clin N Am; 2006 Dec; 12(4):521-31. PubMed ID: 17150429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.